Oncologic Outcome and Immune Responses of Radiotherapy with Anti-PD-1 Treatment for Brain Metastases Regarding Timing and Benefiting Subgroups.
Trommer M, Adams A, Celik E, Fan J, Funken D, Herter JM, Linde P, Morgenthaler J, Wegen S, Mauch C, Franklin C, Galldiks N, Werner JM, Kocher M, Rueß D, Ruge M, Meißner AK, Baues C, Marnitz S.
Trommer M, et al. Among authors: linde p.
Cancers (Basel). 2022 Feb 27;14(5):1240. doi: 10.3390/cancers14051240.
Cancers (Basel). 2022.
PMID: 35267546
Free PMC article.